DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Found vs ShedRx: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Found prints a comparable month-to-month price, $339 per 28-day cycle; ShedRx shows only a starting-dose or coupon figure (from $239, "starting as low as"), so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only Found prints a comparable month-to-month price, $269 per 28-day cycle; ShedRx shows only a starting-dose or coupon figure (from $159, "GLP-1s from $159/mo" (drug not named)), so no like-for-like comparison is possible.

Found and ShedRx, measure by measure

Found and ShedRx side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureFoundShedRx
Tirzepatide, month to month$339 (per 28-day cycle)from $239 (lowest printed: "starting as low as"; no month-to-month figure)
Tirzepatide, lowest printed$199 (12-month term, per 28-day cycle)$239 ("starting as low as")
Semaglutide, month to month$269 (per 28-day cycle)from $159 (lowest printed: "GLP-1s from $159/mo" (drug not named); no month-to-month figure)
Semaglutide, lowest printed$149 (12-month term, per 28-day cycle)$159 ("GLP-1s from $159/mo" (drug not named))
Dose pricingpriced by dose or not statedpriced by dose or not stated
Membership or program feenonenone
Computed score21 of 40 (position 12 of 27)12 of 40 (position 16 of 27)
FDA warning lettersnone listednone listed
November 20 readfirst-party read, changedfirst-party read

Strengths and limitations: which fits whom

Found bills every 28 days, which adds a 13th charge to the year. ShedRx prints a month-to-month price; confirm whether it changes with the dose before you rely on it for a year. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Foundtirzepatide—$339
Foundsemaglutide—$269
ShedRxtirzepatide—from $239
ShedRxsemaglutide—from $159
Check Found’s current prices ↗
Check ShedRx’s current prices ↗

Frequently asked

Which is cheaper, Found or ShedRx?

On compounded tirzepatide, only Found prints a comparable month-to-month price, $339 per 28-day cycle; ShedRx shows only a starting-dose or coupon figure (from $239, "starting as low as"), so no like-for-like comparison is possible. On compounded semaglutide, only Found prints a comparable month-to-month price, $269 per 28-day cycle; ShedRx shows only a starting-dose or coupon figure (from $159, "GLP-1s from $159/mo" (drug not named)), so no like-for-like comparison is possible.

Do Found and ShedRx charge a membership fee?

Found: no membership fee; ShedRx: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Found and ShedRx medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Found recordFound alternativesShedRx recordShedRx alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.